參考文獻(xiàn)/References:
[1] Zondervan K T, Becker C M, Koga K, et al.Endometriosis[J]. Nat Rev Dis Primers,2018,4(1):9.
[2] Nisenblat V, Prentice L, Bossuyt P M, et al.Combination of the non-invasive tests for the diagnosis of endometriosis[J]. Cochrane Database Syst Rev,2016,7(7):D12281.
[3] Meuleman C, Vandenabeele B, Fieuws S, et al.High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners[J]. Fertil Steril,2009,92(1):68-74.
[4] Dunselman G A, Vermeulen N, Becker C, et al.ESHRE guideline: management of women with endometriosis[J]. Hum Reprod,2014,29(3):400-412.
[5] Agarwal S K, Chapron C, Giudice L C, et al.Clinical diagnosis of endometriosis: a call to action[J]. Am J Obstet Gynecol,2019,220(4):351-354.
[6] 李雅男,王丹波,陳英漢,等.不同類(lèi)型子宮內(nèi)膜異位癥臨床特點(diǎn)及意義分析[J]. 實(shí)用婦產(chǎn)科雜志,2015,31(1):34-36.
[7] Nisenblat V,Prentice L,Bossugt P M M,et al.Combination of the non-invasive tests for the diagnosis of endometriosis[J]. Cochrane Database Syst Rev,2016, 7(7):CD012281.
[8] Thezenas M L, De Leo B, Laux-Biehlmann A, et al.Amine oxidase 3 is a novel pro-inflammatory marker of oxidative stress in peritoneal endometriosis lesions[J]. Sci Rep,2020,10(1):1495.
[9] 劉丹,張雪玉,劉瑞,等.深部浸潤(rùn)型與表淺型子宮內(nèi)膜異位癥者腹腔液Th1、Th2細(xì)胞因子變化[J]. 生殖與避孕,2012,32(5):311-315.
[10] Nicolaus K, Reckenbeil L, Brauer D, et al.Cycle-related diarrhea and dysmenorrhea are independent predictors of peritoneal endometriosis, cycle-related dyschezia is an independent predictor of rectal involvement[J]. Geburtshilfe Frauenheilkd,2020,80(3):307-315.
[11] Stilley J A, Birt J A, Sharpe-Timms K L.Cellular and molecular basis for endometriosis-associated infertility[J]. Cell Tissue Res,2012,349(3):849-862.
[12] Saha R, Marions L, Tornvall P.Validity of self-reported endometriosis and endometriosis-related questions in a Swedish female twin cohort[J]. Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society,2017,107(1):174-178.
[13] 張琬琳,王曉紅.子宮內(nèi)膜異位癥相關(guān)不孕診治指南解讀[J]. 實(shí)用婦產(chǎn)科雜志,2018,34(5):341-343.
[14] Schleedoorn M J, Nelen W L, Dunselman G A, et al.Selection of key recommendations for the management of women with endometriosis by an international panel of patients and professionals[J]. Hum Reprod,2016,31(6):1208-1218.
[15] Zondervan K T, Becker C M, Missmer S A.Endometriosis[J]. N Engl J Med,2020,382(13):1244-1256.
[16] Ahn S H, Singh V, Tayade C.Biomarkers in endometriosis: challenges and opportunities[J]. Fertil Steril,2017,107(3):523-532.
[17] Nisenblat V, Bossuyt P M, Shaikh R, et al.Blood biomarkers for the non-invasive diagnosis of endometriosis[J]. Cochrane Database Syst Rev,2016(5):D12179.
[18] Lier M, Vlek S L, Ankersmit M, et al.Comparison of enhanced laparoscopic imaging techniques in endometriosis surgery: a diagnostic accuracy study[J]. Surg Endosc,2020,34(1):96-104.
[19] Tanbo T, Fedorcsak P.Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options[J]. Acta Obstet Gynecol Scand,2017,96(6):659-667.
[20] Giudice L C.Clinical practice.Endometriosis[J]. N Engl J Med,2010,362(25):2389-2398.
[21] 郎景和,崔恒,戴毅,等.2015年子宮內(nèi)膜異位癥的診治指南專(zhuān)家解讀[J]. 中華婦產(chǎn)科雜志,2017,52(12):857-861.
[22] Brown J, Farquhar C.An overview of treatments for endometriosis[J]. JAMA,2015,313(3):296-297.
[23] Singh S S, Suen M W.Surgery for endometriosis: beyond medical therapies[J]. Fertil Steril,2017,107(3):549-554.
[24] Morse C, Senapati S, Barnhart K T, et al.Impact of endometriosis on in vitro fertilization outcomes: an evaluation of the Society for Assisted Reproductive Technologies Database[J]. Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society,2016,106(1):164-171.
[25] Facchin F, Barbara G, Dridi D, et al.Mental health in women with endometriosis: searching for predictors of psychological distress[J]. Hum Reprod,2017,32(9):1855-1861.
相似文獻(xiàn)/References:
[1]張璇 王小紅 林妍 吳小玲.逐瘀湯對(duì)血瘀型子宮內(nèi)膜異位癥性不孕的療效觀察[J].福建醫(yī)藥雜志,2017,39(5):101.
[2]衣 歡 林丹玫 鄭祥欽 吳花敏
林 蓉 莊煒民 楊麗婷.鄰苯二甲酸酯暴露與子宮內(nèi)膜異位癥疼痛關(guān)系的研究[J].福建醫(yī)藥雜志,2019,41(03):5.
YI Huan,LIN Danmei,ZHENG Xiangqin,et al.Study of association between exposure to phthalates and endometriosis-related pain[J].FUJIAN MEDICAL JOURNAL,2019,41(03):5.
[3]張燕,張正紅,林清強(qiáng),等.雌激素在子宮內(nèi)膜異位癥中的作用及其調(diào)控[J].福建醫(yī)藥雜志,2021,43(03):119.
[4]王貞娜,姜雯雯,王真紅,等.子宮內(nèi)膜異位癥在位內(nèi)膜中自噬相關(guān)基因及ceRNA網(wǎng)絡(luò)的作用[J].福建醫(yī)藥雜志,2022,44(06):20.
WANG Zhenna,JIANG Wenwen,WANG Zhenhong,et al.Effect of autophagy-related genes and ceRNA network in endometriosis eutopic endometrium[J].FUJIAN MEDICAL JOURNAL,2022,44(03):20.